Filing Details

Accession Number:
0001493152-22-007285
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-18 17:26:04
Reporting Period:
2022-03-17
Accepted Time:
2022-03-18 17:26:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1862150 Cingulate Inc. CING Pharmaceutical Preparations (2834) 863825535
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1883257 J. Peter Werth 1901 W. 47Th Place
Kansas City KS 66205
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-03-17 27,000 $1.79 871,731 No 4 P Indirect By Werth Family Investment Associates LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Werth Family Investment Associates LLC
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 21,849 Direct
Footnotes
  1. Reporting person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.